Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension
ConclusionsUcn-2 levels are altered in human and experimental PAH. hUcn-2 treatment attenuates PAH and RV dysfunction in MCT-induced PH, has direct anti-remodelling effects on the pressure-overloaded RV, and improves pulmonary vascular function.
Source: Cardiovascular Research - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Genetics | Heart | Heart Failure | Hypertension | Pulmonary Hypertension | Sports Medicine